Back

Risk predictors of cardiac allograft vasculopathy after heart transplantation: Results from the United States Organ Procurement and Transplantation Network

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Stage D Heart Failure Heart Transplantation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Nina Becher

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

9 More presentations in this session

Presentation thumbnail
Is the new PH classification useful to assess the need for heart transplantation? Looking for harder markers for hard patients.
Doctor A. Moretta (Imola, IT)
Abstract Slides
Presentation thumbnail
Pregnancy outcomes in women with cardiothoracic transplants: a systematic review and meta-analysis
Ms S. Dong (Toronto, CA)
Abstract Slides
Presentation thumbnail
RAAS inhibition improves event-free survival in cardiac transplant recipients: results of the prospective cohort study
Professor A. Shevchenko (Moscow, RU)
Abstract Slides
Presentation thumbnail
Left- versus Bi- Ventricular Assist Device-mediated anti-HLA alloantibody induction in bridge-to-transplantation patients
Doctor I. Armenis (Nicosia, CY)
Abstract
Presentation thumbnail
Effects of chronic heart failure unconventional therapies on endothelial function
Doctor M. Cipriani (Palermo, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Stage D Heart Failure

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Dealing with Heart Failure (again) after Cardiac Transplant
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Hemochromatosis-induced cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources